Venclose Revenue and Competitors
Estimated Revenue & Valuation
- Venclose's estimated annual revenue is currently $6.1M per year.
- Venclose's estimated revenue per employee is $125,500
- Venclose's total funding is $27M.
Employee Data
- Venclose has 49 Employees.
- Venclose grew their employee count by -18% last year.
Venclose's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman & CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | COO | Reveal Email/Phone |
4 | VP Market Development | Reveal Email/Phone |
5 | VP Research & Development | Reveal Email/Phone |
6 | SVP, Global Sales & Marketing | Reveal Email/Phone |
7 | VP, Sales Europe/Middle East | Reveal Email/Phone |
8 | VP Sales and Marketing Europe | Reveal Email/Phone |
9 | Director Clinical Education & Training | Reveal Email/Phone |
10 | Director R&D, Product Development | Reveal Email/Phone |
Venclose Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.1M | 96 | 19% | N/A | N/A |
#2 | $9.5M | 38 | 12% | N/A | N/A |
#3 | $4M | 16 | -11% | N/A | N/A |
#4 | $7.8M | 31 | -3% | N/A | N/A |
#5 | $5M | 20 | -5% | N/A | N/A |
#6 | $49.9M | 199 | -8% | N/A | N/A |
#7 | $16.8M | 67 | -17% | $63.2M | N/A |
#8 | $9.3M | 37 | -7% | N/A | N/A |
#9 | $36.6M | 146 | 22% | N/A | N/A |
#10 | $64.3M | 205 | 3% | $502M | N/A |
What Is Venclose?
We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults. Our Mission To improve the physician and patient experience during chronic venous insufficiency treatment by commercializing the next-generation RF therapy.
keywords:N/A
$27M
Total Funding
49
Number of Employees
$6.1M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Venclose News
SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ -- Venclose Inc., a privately-held medical device corporation focused on innovative advancements for the minimally invasive treatment of chronic venous insufficiency, a major underlying cause of varicose veins, today announced that Jerry Gibson, Ven ...
SAN JOSE, Calif., Dec. 3, 2019 /PRNewswire/ — Venclose, Inc., a privately-held Silicon Valley medical device company focused on innovative treatment procedures for venous reflux disease, today announced it has closed its Series C funding led by Ally Bridge Group (ABG). ABG is a global life scien ...
Venous reflux disease treatment developer Venclose announced that it closed a Series C funding round totaling $27 million. Venclose develops the next-generation Venclose RF ablation system designed to close damaged veins and restore healthy blood flow in patients with venous reflux disease. Th ...
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.2M | 49 | -21% | $88M |
#2 | $9.8M | 49 | 0% | N/A |
#3 | $5.7M | 49 | -4% | N/A |
#4 | $10.8M | 49 | 7% | N/A |
#5 | $6.7M | 49 | 0% | N/A |